XML 33 R23.htm IDEA: XBRL DOCUMENT

Legal Settlements and Loss Contingencies	6 Months Ended
Jun. 30, 2019
Legal Settlements and Loss Contingencies	NOTE 15 – Legal settlements and loss contingencies: In the second quarter of 2019, Teva recorded an expense of $646 million in legal settlements and loss contingencies , compared to $20 million in the second quarter of 2018. The expense in the second quarter of 2019 was mainly related to the $85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made for certain other opioid cases. In the first six months of 2019 , Teva recorded an expense of $703 million in legal settlements and loss contingencies , compared to income of $1,258 million in the first six months of 2018. The expense in the first six months of 2019 was mainly related to the $85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made for certain other opioid cases . As of June 30, 2019 and December 31, 2018, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses was $1,149 million and $562 million, respectively.

Legal Settlements and Loss Contingencies

6 Months Ended

Jun. 30, 2019

Legal Settlements and Loss Contingencies

NOTE 15 – Legal settlements and loss contingencies:

In the second quarter of 2019, Teva recorded an expense of $646 million in legal

settlements and loss contingencies

, compared to $20 million in the second quarter of 2018. The expense in the second quarter of 2019 was mainly related to the $85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made

for

certain other opioid cases.

the first six months of 2019

, Teva recorded

an expense of $703 million

in legal settlements and loss contingencies

, compared to income of $1,258 million in the first six months of 2018. The expense in the first six months of 2019

was mainly

related to the

$85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made for certain other opioid cases

As of June 30, 2019 and December 31, 2018, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses was $1,149 million and $562 million, respectively.